Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 2/20 | 0.63 |
| ▸ | PARP1 | P09874 | 1/20 | 0.63 |
| ▸ | XDH | P47989 | 1/20 | 0.61 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.58 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.54 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.54 |
| ▸ | CNR2 | P34972 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.54 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.54 |
| ▸ | PPARD | Q03181 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8118653 | 0.89 | TNKS (0.79) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL9319191 | 0.87 | TNKS (0.56) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL31518908 | 0.85 | TNKS (0.54) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL31518888 | 0.85 | TNKS (0.54) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL17969003 | 0.83 | XDH (0.59) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL18338811 | 0.82 | TNKS (0.84) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL28430099 | 0.82 | TNKS (0.51) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL30106410 | 0.82 | TNKS (0.84) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL17546624 | 0.80 | TNKS (0.68) | TNKSPARP1XDHTNKS2GABRA1 | |
| SCHEMBL19677147 | 0.79 | TNKS (0.66) | TNKSPARP1XDHTNKS2GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591769-A | Organic polymer carrier, Z-N catalyst, and preparation method and application thereof | 中国石油天然气股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-116425613-A | Synthesis method of 5-allyl pyrogallol | 苏州当量生物医药有限公司 | 2023-07-14 | — | — | CN | claimed |
| US-20230001046-A1 | BIOCOMPATIBLE ADHESIVES AND METHODS OF MANUFACTURE THEREOF | GOVERNING COUNCIL UNIV TORONTO (CA) | 2023-01-05 | — | — | US | claimed |
| WO-2022261791-A1 | AMPHIPHILIC OLIGOMERS AND SELF-ASSEMBLING HYDROGELS FORMED THEREFROM | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2022-12-22 | — | — | WO | claimed |
| US-20220395608-A1 | WATER SOLUBLE BIOADHESIVES | GOVERNING COUNCIL UNIV TORONTO (CA) | 2022-12-15 | — | — | US | claimed |
| WO-2021119855-A1 | WATER SOLUBLE BIOADHESIVES | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2021-06-24 | — | — | WO | claimed |
| US-4172960-A | ETHERIFICATION, DEETHERIFICATION, DIALKYLATION | FISONS LIMITED (GB) | 1979-10-30 | — | — | US | claimed |
| US-20250090480-A1 | UNIQUE ANALOGS OF NATURAL LIGNANS USEFUL FOR TREATING TRIPLE NEGATIVE BREAST CANCER | UNIV KENTUCKY RES FOUND (US) | 2025-03-20 | — | — | US | disclosed |
| CN-119591769-A | Organic polymer carrier, Z-N catalyst, and preparation method and application thereof | 中国石油天然气股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| WO-2024237320-A1 | MEDICAL POLYMER COMPOSITION AND MEDICAL ADHESIVE CONTAINING SAME | 東洋紡株式会社 | 2024-11-21 | — | — | WO | disclosed |
| WO-2024237321-A1 | METHOD FOR CURING POLYMER COMPOSITION IN CONTACT WITH MEDICAL SUBSTRATE | 東洋紡株式会社 | 2024-11-21 | — | — | WO | disclosed |
| CN-116425613-A | Synthesis method of 5-allyl pyrogallol | 苏州当量生物医药有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116425613-A | Synthesis method of 5-allyl pyrogallol | 苏州当量生物医药有限公司 | 2023-07-14 | — | — | CN | disclosed |
| WO-2011106630-A2 | CHRYSOPHAENTIN ANTIMICROBIAL COMPOUNDS THAT INHIBIT FTSZ PROTEIN | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2011-09-01 | — | — | WO | disclosed |
| US-5779906-A | Method of removing heavy metal ions from a liquid with chemically active ceramic compositions with a pyrogallol moiety | SYRACUSE UNIVERSITY (US) | 1998-07-14 | — | — | US | disclosed |
| US-5624881-A | Chemically active ceramic compositions with a pyrogallol moiety | SYRACUSE UNIVERSITY (US) | 1997-04-29 | — | — | US | disclosed |
| WO-1996009885-A1 | CHEMICALLY ACTIVE CERAMIC COMPOSITIONS WITH A PYROGALLOL MOIETY | SYRACUSE UNIVERSITY (US) | 1996-04-04 | — | — | WO | disclosed |
| US-5087548-A | POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION | JAPAN SYNTHETIC RUBBER CO., INC. (JP) | 1992-02-11 | — | — | US | disclosed |
| EP-0227487-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-07-01 | — | — | EP | disclosed |
| US-4172960-A | ETHERIFICATION, DEETHERIFICATION, DIALKYLATION | FISONS LIMITED (GB) | 1979-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090480-A1 | UNIQUE ANALOGS OF NATURAL LIGNANS USEFUL FOR TREATING TRIPLE NEGATIVE BREAST CANCER | BRCA1, GALK1, BRAP | TNKS 315/4885PARP1 351/4885XDH 2763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.